[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-ukri-longitudinal-population-studies-strategic-prioriti-2026-11":3,"similar-ukri-longitudinal-population-studies-strategic-prioriti-2026-11":38},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":11,"deadline_note":12,"duration":13,"trl":9,"relevance":9,"why_relevant":9,"early_career":14,"consortium":15,"first_seen":16,"last_updated":9,"update_note":9,"status":17,"stages":18,"call_frequency":19,"next_call_expected":9,"source_url":7,"created_at":20,"updated_at":21,"last_seen_at":20,"eligible_countries":22,"description":24,"seo_summary":25,"recurring_round":14,"canonical_id":4,"links":26},"ukri-longitudinal-population-studies-strategic-prioriti-2026-11","Longitudinal Population Studies Strategic Prioritisation Exercise","UKRI","https:\u002F\u002Fwww.ukri.org\u002Fopportunity\u002Flongitudinal-population-studies-strategic-prioritisation-exercise\u002F","Phase 1 up to £1M\u002Fyear; Phase 2 up to £200k\u002Fyear",null,1170000,"2026-11-17T00:00:00.000Z","16:00 UK time","10 years (nominally 2029–2039); shorter for Phase 3 studies",false,"Optional — international researchers may join as project co-lead (international) or project partners; businesses and charities may participate as project partners only","2026-09-20T00:00:00.000Z","open","Single stage","One-off","2026-09-20T08:14:51.471Z","2026-09-20T09:25:01.965Z",[23],"GB","Strategic Prioritisation Exercise (SPE) for existing biomedical Longitudinal Population Studies (LPS) based in the UK, or overseas if previously MRC-supported with a UK research organisation involved. Submissions will not result in direct funding but inform future MRC investment; project leads must be UK-based researchers at eligible research organisations.","{\"summary\":\"This UKRI exercise asks existing biomedical Longitudinal Population Studies to submit strategic proposals that will inform future MRC investment rather than deliver direct funding. It is open to UK-based project leads at eligible research organisations running established LPS cohorts, including studies based overseas if previously MRC-supported with a UK research organisation involved. Proposals feed a prioritisation process covering funding phases from nominally 2029 to 2039, with shorter timelines for Phase 3 studies.\",\"meta_description\":\"UKRI exercise for existing UK longitudinal population studies to submit strategic proposals informing future MRC funding, deadline 17 November 2026.\",\"who_should_apply\":[\"Project leads of existing biomedical Longitudinal Population Studies\",\"UK-based researchers at eligible research organisations\",\"Overseas LPS previously MRC-supported with a UK research organisation partner\",\"Studies seeking to inform long-term MRC investment rather than immediate funding\"],\"key_dates\":[\"Deadline 17 November 2026, 16:00 UK time\",\"Single-stage application\",\"Funding phases run nominally 2029-2039, shorter for Phase 3 studies\"],\"tips\":[\"This is a prioritisation exercise, not a funding call, frame the submission around strategic case and long-term value rather than a standard grant narrative.\",\"International co-leads and business or charity partners can join, but only UK-based researchers may act as project lead, check consortium roles before drafting.\",\"Distinguish clearly between Phase 1, Phase 2 and Phase 3 study status, since budget scale and duration expectations differ sharply between them.\"],\"faq\":[{\"q\":\"Does the UKRI Longitudinal Population Studies Strategic Prioritisation Exercise provide direct funding?\",\"a\":\"No, submissions do not result in direct funding but inform future MRC investment decisions.\"},{\"q\":\"Who can be project lead for this exercise?\",\"a\":\"Project leads must be UK-based researchers at eligible research organisations.\"},{\"q\":\"Can overseas studies apply?\",\"a\":\"Yes, if the study was previously MRC-supported and a UK research organisation is involved.\"},{\"q\":\"What is the budget for this exercise?\",\"a\":\"Phase 1 studies are considered up to £1M per year and Phase 2 studies up to £200k per year.\"},{\"q\":\"How long do the funding phases last?\",\"a\":\"Duration is nominally ten years, from 2029 to 2039, though Phase 3 studies have shorter timelines.\"}],\"tags\":[\"longitudinal-population-studies\",\"ukri\",\"mrc\",\"cohort-studies\",\"strategic-review\",\"uk-only\",\"biomedical-research\"]}",{"matchedProgram":9,"resourceSlug":27,"relatedGuides":28,"countryHubs":29,"domainHubs":33,"closingMonth":34,"hasRelated":37,"hasBrowseRelated":37},"ukri",[],[30],{"slug":31,"demonym":32},"gb","UK researchers",[],{"slug":35,"label":36},"2026-11","November 2026",true,{"grants":39},[40,46,51,56,62],{"id":41,"name":42,"funder":43,"deadline":44,"budget":45},"mrc-ukri-centre-of-research-excellence-2027-02","Centre of Research Excellence","MRC (UKRI)","2027-02-03T00:00:00.000Z","Up to £26.25M FEC; MRC contribution up to £21M (incl. up to £500,000 start-up equipment costs)",{"id":47,"name":48,"funder":49,"deadline":50,"budget":9},"nihr-james-lind-alliance-priority-setting-partnerships--2026-11","James Lind Alliance Priority Setting Partnerships Rolling Funding Opportunity","NIHR","2026-11-25T00:00:00.000Z",{"id":52,"name":53,"funder":43,"deadline":54,"budget":55},"mrc-ukri-translation-mrc-impact-acceleration-awards-2026-11","Translation MRC Impact Acceleration Awards","2026-11-11T00:00:00.000Z","£50k–£300k FEC (80% funded, i.e. up to £240k awarded)",{"id":57,"name":58,"funder":59,"deadline":60,"budget":61},"medical-research-council-mrc-mrc-experimental-medicine-2026-10","MRC Experimental Medicine","Medical Research Council (MRC)","2026-10-07T00:00:00.000Z","No limit stated; 80% of full economic cost funded",{"id":63,"name":64,"funder":43,"deadline":65,"budget":66},"mrc-ukri-centres-of-excellence-for-regulatory-science-and-i-2027-01","Centres of Excellence for Regulatory Science and Innovation","2027-01-12T00:00:00.000Z","Up to £5M over five years (max £3M for first three years)"]